Weekly Market Update – 17th December 2021

• Global share markets were mixed over the past week with worries about the latest coronavirus wave and central bank monetary tightening causing volatility and tech stocks remaining under pressure. European and Japanese shares rose but US and Chinese shares fell. The soft global lead not helped by surging coronavirus cases locally saw the Australian share market fall with declines in health, IT and retail stocks offsetting gains in material, utility and property stocks. Long term bond yields mostly fell, but oil and metal prices rose along with the $A.

• While there are numerous risks around – Omicron, inflation, tensions with China and Russia, etc – the Santa rally normally kicks in around mid-December on the back of festive cheer and new year optimism, the investment of any bonuses, low volumes and no capital raisings. Over the last ten years the period from mid-December to year end has seen an average gain of 0.4% in US shares with shares up in this two-week period 6 years out of ten. In Australia, over the last ten years the average gain over the last two weeks of December has been 1.4% with shares up 7 years out of ten, although it hasn’t worked over the last two years.

• Central banks heading towards tighter monetary policy – but at different speeds and monetary policy looks likely to remain easy next year. The Fed sped up the taper and is now flagging three hikes next year with Fed Chair Powell sounding more hawkish. Quantitative easing in the US is now set to end in March clearing the way for the first hike in the June quarter. The ECB confirmed it will end its pandemic emergency QE program as scheduled in March but will increase its regular bond purchases to smooth the adjustment. The ECB remains relatively dovish and rate hikes look unlikely until 2023. The BoE raised its cash rate for the first time to 0.25% with inflation concerns dominating Omicron uncertainty. The BoJ largely left its monetary stimulus unchanged although it will pare back its holdings of corporate debt. In Australia, Governor Lowe flagged a likely end to QE in May but continued to push back against expectations for rate hikes in 2022. The upshot is that key central banks are moving towards monetary tightening, but at different speeds.

• The dot plot of Fed officials’ interest rate expectations does not see rates getting above its perceived neutral or long run level out to 2024. This may pose risks for inflation – but it’s also important for the economic cycle. While first rate hikes in tightening cycles can cause corrections its usually only when monetary policy becomes tight after numerous rate hikes (17 by the Fed prior to the GFC, 9 prior to the 2018 US share market slump) that it becomes a problem for the economy and share markets. But tight monetary policy still looks to be a long way off. It’s the same in Australia – there are expectations for two rate hikes next year taking the cash rate to 0.5% by year end will still leave Australian monetary policy ultra-easy.

• Global coronavirus cases flattened out a bit over the last week as cases in Europe fell slightly (with Germany, Austria and the Netherlands down, but France, Italy and Spain up). But it’s still early days in the Omicron wave which is now combining with the latest Delta wave, the northern hemisphere winter, waning immunity and inadequate booster rollouts to push cases higher. And the US data has been a little volatile of late. That said it’s still nice to see the level of deaths relative to new cases remaining subdued compared to that seen in prior waves.

Source: ourworldindata.org, AMP

• What we know about Omicron so far. This is still evolving, but the bad news is that: Omicron is still looking a lot more transmissible than Delta (possibly 4 times more) and will likely quickly come to dominate global cases (its already about 98% of new cases in South Africa); it results in substantially less protection from vaccines against infection (possibly to zero for AstraZeneca and to around 35% for Pfizer 15 weeks out from the second dose); China’s Sinovac vaccine may provide no protection; and it may take out to the June quarter to devise Omicron specific vaccines. Against this though: it seems to result in milder symptoms (with South Africa seeing a lower share of patients in ICU and on ventilators and shorter hospital stays); the Pfizer vaccine may provide 70% protection against being hospitalised; a booster shot from a mRNA vaccine (Pfizer or Moderna) appears to offer significant protection (up to 98%) against severe disease and hospitalisation.

Source: ourworldindata.org, South African Health, AMP

• It’s still too early to be definitive, particularly given that much of the information has come from South Africa which has a high level of prior exposure & a younger population which may help to keep serious illness down. Nevertheless, the news on booster shots which has been confirmed by several studies is positive.

• The optimistic scenario is that if Omicron is confirmed to be less virulent but due to its greater transmissibility comes to dominate the other variants it could turn out to be a good thing as it could put Covid-19 on a path to becoming like the common cold or flu. The high risk though is that if too many get it at once due its greater transmissibility, hospitals could still be overwhelmed even if only a smaller proportion of those who get it get seriously ill – so it makes sense to use various restrictions (like mask and vaccine mandates) to slow its transmission down. Particularly until more have had booster shots and new covid treatments become widely available. This explains why various countries including the UK have returned some restrictions after virtually eliminating them, in order to slow new cases and ensure hospitals can cope. So far hospitalisation and death rates in Europe remain subdued relative to the wave a year ago. This is also the case in the UK where new cases are now rising rapidly.

Source: ourworldindata.org, AMP

Source: ourworldindata.org, AMP

• 45% of the global population are now fully vaccinated – but in poor countries it’s just 18%. Australia at 76% of the population fully vaccinated is at the high end of developed countries where the average is 69%. But given their importance in protecting against Omicron the focus will now shift to booster shots. So far just less than 4% of Australia’s population has had a booster – which along with a low degree of natural immunity leaves Australia vulnerable to the Omicron wave.

Source: ourworldindata.org, AMP

• NSW and Victoria are now seeing the reopening surge in cases that has been common to many other countries after reopening. And with border reopenings cases are surging in other states too. A further massive surge in new cases is looking inevitable as Omicron spreads helped along by Christmas gatherings. So far, hospitalisations and deaths remain subdued, but they lag and hospitalisations are starting to pick up – they will be the key to watch.

Source: ourworldindata.org, AMP

• The Australian Economic Activity Tracker edged higher again over the last week with broad based gains in mobility, restaurant and hotel bookings and shopper traffic. However, it’s likely that self-regulation in the face of surging covid cases will start to weigh in the weeks ahead. The European and US Economic Activity Trackers also improved slightly although rising cases and restrictions could start to become more of a drag.

Based on weekly data for eg job ads, restaurant bookings, confidence, mobility, credit & debit card transactions, retail foot traffic, hotel bookings. Source: AMP

• Business conditions PMIs in Europe, the US, the UK, Japan and Australia all fell slightly in December with rising covid cases impacting. But they remain solid. Price indicators generally remain high (down in Europe but up in the US).

Source: Bloomberg, AMP

• US data was mixed. Retail sales and industrial production rose but by less than expected. Business conditions PMIs and surveys pulled back a bit on average but remain very strong. Jobless claims rose but remain historically low. Housing starts, permits to build new homes and the NAHB home building conditions index were all strong. The downside is that producer price inflation rose to a new high of 9.6%yoy.

• Eurozone business conditions PMIs fell further in December but remain reasonable. Price pressures eased though. PMIs also fell in the UK.

• The Japanese Tankan business survey showed that conditions were mostly firm in the December quarter, while the PMI fell slightly in December.

• Chinese economic activity for November was mostly weaker. Growth in industrial production accelerated but retail sales and investment growth slowed, home prices fell for the third month in a row and unemployment rose slightly. The fall in retail sales growth may have been impacted by covid restrictions and a shift in the iPhone release cycle, but the data overall is consistent with more policy easing ahead as signalled by the recent Politburo meeting.

• Australian economic data was mostly solid. Employment rebounded by 366,000 in November fully recovering the east coast lockdown hit and pushing unemployment down to 4.6%. The latest lockdowns clearly had a far less negative impact on businesses and labour demand than last year’s lockdowns as Australians seem to be better at managing them. While labour force participation is not the issue that it is in the US, strong demand for labour is still resulting in a very tight labour market and unemployment is expected to fall to 4% by the end of next year putting in place the conditions for the RBA to start hiking rates in November. Meanwhile, business confidence as measured by the NAB survey, December business conditions PMIs and consumer confidence remain solid and new housing demand according to the latest HIA survey remains strong.

Source: ABS, AMP

• While RBA Governor Lowe continues to push back against the prospect for 2022 rate hikes the RBA will ultimately be governed by “data and forecasts” rather than calendar years and views are that the data and forecasts will ultimately justify late 2022 rate hikes. In the interim continue to see the RBA further reducing its bond buying in February to $2bn a week ahead of an end to bond buying in May. This appears to be consistent with the RBA’s central case as noted by Governor Lowe.

• Of course, the main and now rising threat to this would be a severe new coronavirus wave that threatens to overwhelm the hospital system necessitating a return to hard lockdowns, and a delay to the removal of monetary stimulus.

• MYEFO sees more revenue but more spending too and ever bigger government. While the combination of a stronger jobs market, higher wages forecasts and higher corporate revenue saw the Government revise up its revenue estimates by $47bn for the four years to 2024-25 this was largely offset by extra spending on covid support, the NDIS and unspecified election promises. So, over the four years the budget deficit is projected to be only fractionally lower and projected longer term government spending has crept up yet again to 26.5% of GDP (from the 24.8% average that prevailed pre covid). Bigger government looks to be getting entrenched.

Source: RBA, Australian Treasury, AMP

• In the US, expect a slight rise in consumer confidence (due 22 Dec), solid gains in durable goods orders and personal spending and a further acceleration in core private final consumption deflator inflation to 4.5%yoy (23 Dec), a slight fall back in the December manufacturing ISM index (4 Jan) and a 500,000 rise in payrolls with unemployment falling further to 4.1% (7 Jan). The minutes from the December Fed meeting will be released on 5 Jan.

• Eurozone core inflation for December (7 Jan) will likely show a further rise to 3%yoy.

• Japanese core inflation for December (24 Dec) will likely remain around zero.

• China’s business conditions PMIs (due 31 Dec and early Jan) will likely remain around 50.

• In Australia, November credit growth (31 Dec) is likely to pick up to around 0.6%mom with faster home investor lending but to remain soft and CoreLogic home price data for December (4 Jan) will likely show a further slowing in home price growth to 0.5%mom leaving prices up 21% for 2021. The minutes from last RBA meeting (21 Dec) are unlikely to add much.

• Global shares are expected to return around 8% but expect to see the long-awaited rotation away from growth & tech heavy US shares to more cyclical markets in Europe, Japan & emerging countries. Inflation, the start of Fed rate hikes, the US mid-term elections & China/Russia/Iran tensions are likely to result in a more volatile ride than 2021. Mid-term election years normally see below average returns in US shares and since 1950, have seen an average top-to-bottom drawdown of 17%, usually followed by a stronger rebound.

• Australian shares are likely to outperform (at last) helped by stronger economic growth than in other developed countries, leverage to the global cyclical recovery and as investors continue to search for yield in the face of near zero deposit rates but a grossed-up dividend yield of around 5%. Expect the ASX 200 to end 2021 around 7,800.

• Still very low yields & a capital loss from a rise in yields are likely to again result in negative returns from bonds.

• Unlisted commercial property may see some weakness in retail and office returns, but industrial is likely to be strong. Unlisted infrastructure is expected to see solid returns.

• Australian home price gains are likely to slow with prices falling later in the year as poor affordability, rising fixed rates, higher interest rate serviceability buffers, reduced home buyer incentives and rising listings impact.

• Cash and bank deposits are likely to provide very poor returns, given the ultra-low cash rate of just 0.1%.

• Although the $A could fall further in response to coronavirus and Fed tightening, a rising trend is likely over the next 12 months helped by still strong commodity prices and a decline in the $US, probably taking it to around $US0.80.

AMP Capital Investors Limited and AMP Capital Funds Management Limited Disclaimer

FinSec Partners Disclaimer